EAG Scientists Present Research at SciX 2024
EAG Scientists present research at SciX 2024 focused on compositional analysis and provenience studies of natural iron oxides pigments.
EAG Successfully Completes ISO 17025 Accreditation Expanding Scope to RGA Testing
Recently, Eurofins EAG Laboratories (EAG) completed their ISO 17025 accreditation and expanded the scope to include testing performed by Residual Gas Analysis (RGA). RGA testing is primarily used to perform internal gas analysis in microelectronic hermetic devices as per the MIL-STD 883. Internal gas analysis for hermetic devices that includes implantable medical devices is the only testing to determine gas composition inside the sealed devices. The composition of internal gas plays a critical role in the performance and longevity of devices.
ISO 17025 is an international standard that sets out the requirements for the competence of testing and calibration of laboratories. It is recognized by most countries around the world,
and it is a requirement for many regulatory agencies. This accreditation provides the assurance that the testing laboratory has the necessary competence to perform testing and calibration services accurately and consistently. Second, it demonstrates that the laboratory has a robust quality management system in place. RGA testing at EAG recently achieved the required suitability to perform MIL-STD testing. Now, with RGA included in the scope of ISO 17025, RGA testing at EAG is a premium choice to perform gas analysis. Medical device manufacturers are increasingly opting for ISO 17025 vendors/suppliers because they need to ensure that the components and materials used in their products meet the required quality standards. By working with an accredited vendor/supplier, medical device manufacturers can reduce the risk of product recalls and other issues that may arise. Some additional benefits of ISO 17025 accreditation include medical device manufacturers include increased confidence in the quality of test and calibration results, increased market opportunities, improved customer satisfaction, and reduced costs.
For medical devices and biomaterial companies, EAG offers the most diverse and comprehensive suite of testing and engineering support available. EAG Laboratories has established itself within the technology and biomedical space by developing scientific expertise in difficult analytical measurements, characterizations of complex materials and systems, and a pioneering approach to problem-solving. Contact us today to learn more about how EAG’s ISO 17025 Accreditation would be a benefit for you.
More content you might like...
Frequently Asked Questions About In Vitro Irritation and Cytotoxicity Testing
Biocompatibility assessments are a battery of tests performed to evaluate a product, medical device, or other material for the risk of biological hazards.
The Conspicuous Case of the Missing T0 in ISO 10993-5 Cytotoxicity Testing
In the world of medical device safety testing, ISO 10993-5 plays a crucial role. A key aspect of this, which is sometimes overlooked in certain studies, is the T0 time point, or time zero.
Rare Earth Elements Aren’t So Rare After All
The term ‘rare earth elements’ (REEs) is a misnomer and better refers to the relatively rare ores REEs are extracted from; rare earth elements are all around us!